Talis Biomedical Corporation TLIS
€ 4.16
3.55%
Quartalsbericht 2024-Q2
hinzugefügt 19.08.2024
Talis Biomedical Corporation Bilanz 2011-2024 | TLIS
Bilanz Jährlich Talis Biomedical Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-57.1 M | -96.6 M | -219 M | -138 M | -21.6 M | -6.9 M | - | - | - | - | - | - | - |
Langfristige Schulden |
16.8 M | 29.9 M | 12.7 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
2.88 M | 3.7 M | 1.23 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 5 K | 42.8 M | 60 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
8.77 M | 12.7 M | 19.1 M | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
25.6 M | 42.6 M | 31.9 M | 16 M | 46.9 M | 63.4 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-540 M | -478 M | -365 M | - | -81.8 M | -54.3 M | - | - | - | - | - | - | - |
Vermögenswerte |
94.7 M | 169 M | 266 M | 198 M | 25.7 M | 11.4 M | - | - | - | - | - | - | - |
Zahlungsmittel |
76.7 M | 130 M | 233 M | 173 M | - | - | - | - | - | - | - | - | - |
Buchwert |
69.1 M | 127 M | 234 M | 182 M | -21.1 M | -52 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
69.1 M | 127 M | 234 M | -109 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Talis Biomedical Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
15.9 M | 16.3 M | 16.8 M | 17.2 M | 17.6 M | 11.7 M | 29.9 M | 30.3 M | - | 12.5 M | 12.7 M | 13 M | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
24.1 M | 25.8 M | 25.6 M | 25.7 M | 26.9 M | 22.9 M | 42.6 M | 41.7 M | - | 27.8 M | 31.9 M | 44.3 M | 85.8 M | - | 16 M | 16 M | 16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-562 M | -553 M | -540 M | -527 M | -511 M | -496 M | -478 M | -451 M | - | -398 M | -365 M | -336 M | -298 M | -233 M | -173 M | -173 M | -173 M | -173 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
72.7 M | 82.5 M | 94.7 M | 107 M | 123 M | 133 M | 169 M | 194 M | - | 231 M | 266 M | 303 M | 380 M | 403 M | 198 M | 198 M | 198 M | 198 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
59.9 M | 70.3 M | 76.7 M | 88 M | 98.2 M | 113 M | 130 M | 144 M | 165 M | 188 M | 233 M | 274 M | 313 M | 348 M | 138 M | 138 M | 138 M | 138 M | 21.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
48.6 M | 56.7 M | 69.1 M | 81.6 M | 96.2 M | 110 M | 127 M | 152 M | - | 203 M | 234 M | 259 M | 294 M | 403 M | 182 M | 182 M | 182 M | 198 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
48.6 M | 56.7 M | 69.1 M | 81.6 M | 96.2 M | 110 M | 127 M | 152 M | 177 M | 203 M | 234 M | 259 M | 294 M | 356 M | -109 M | -109 M | -109 M | -109 M | -21.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung